CN103814042B - 具有抗病毒活性的桦木酸衍生物 - Google Patents
具有抗病毒活性的桦木酸衍生物 Download PDFInfo
- Publication number
- CN103814042B CN103814042B CN201280046037.7A CN201280046037A CN103814042B CN 103814042 B CN103814042 B CN 103814042B CN 201280046037 A CN201280046037 A CN 201280046037A CN 103814042 B CN103814042 B CN 103814042B
- Authority
- CN
- China
- Prior art keywords
- hiv
- alkyl
- compounds
- group
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CC*C1OC(*)CN(C)C1 Chemical compound CC*C1OC(*)CN(C)C1 0.000 description 7
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161537099P | 2011-09-21 | 2011-09-21 | |
| US61/537,099 | 2011-09-21 | ||
| PCT/US2012/056186 WO2013043778A1 (en) | 2011-09-21 | 2012-09-20 | Novel betulinic acid derivatives with antiviral activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103814042A CN103814042A (zh) | 2014-05-21 |
| CN103814042B true CN103814042B (zh) | 2015-08-19 |
Family
ID=46964090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280046037.7A Expired - Fee Related CN103814042B (zh) | 2011-09-21 | 2012-09-20 | 具有抗病毒活性的桦木酸衍生物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8754069B2 (enExample) |
| EP (1) | EP2758419B8 (enExample) |
| JP (1) | JP6100786B2 (enExample) |
| KR (1) | KR20140069167A (enExample) |
| CN (1) | CN103814042B (enExample) |
| AU (1) | AU2012312485B2 (enExample) |
| BR (1) | BR112014006559A2 (enExample) |
| CA (1) | CA2849475A1 (enExample) |
| EA (1) | EA023463B1 (enExample) |
| ES (1) | ES2611727T3 (enExample) |
| IL (1) | IL231421A (enExample) |
| MX (1) | MX2014002936A (enExample) |
| SG (1) | SG11201400331WA (enExample) |
| TW (1) | TW201317255A (enExample) |
| WO (1) | WO2013043778A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8906889B2 (en) | 2012-02-15 | 2014-12-09 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
| US8889854B2 (en) | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
| WO2016168447A1 (en) * | 2015-04-14 | 2016-10-20 | VIIV HEALTHCARE (No.4) LIMITED | Methods of producing an hiv maturation inhibitor |
| EP3328876A1 (en) | 2015-07-28 | 2018-06-06 | Glaxosmithkline Intellectual Property (No. 2) Limited | Betuin derivatives for preventing or treating hiv infections |
| KR20180028535A (ko) | 2015-07-28 | 2018-03-16 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | Hiv 감염을 예방하거나 치료하기 위한 베투인 유도체 |
| AU2016327169A1 (en) | 2015-09-24 | 2018-04-12 | Glaxosmithkline Intellectual Property (No.2) Limited | Compounds with hiv maturation inhibitory activity |
| JP2019502728A (ja) | 2016-01-20 | 2019-01-31 | グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ | Ｈｉｖ成熟阻害活性を有するルパンのアミン誘導体 |
| US20190307776A1 (en) * | 2016-06-30 | 2019-10-10 | Viiv Healthcare Uk (No. 5) Limited | Aza-substituted inhibitors of human immunodeficiency virus replication |
| EP3784349B1 (en) | 2018-04-24 | 2023-12-27 | VIIV Healthcare UK (No.5) Limited | Compounds with hiv maturation inhibitory activity |
| WO2020006510A1 (en) * | 2018-06-29 | 2020-01-02 | Dfh Therapeutics | Triterpene amine derivatives |
| US12275712B2 (en) | 2019-02-11 | 2025-04-15 | Hetero Labs Limited | Triterpene derivatives as HIV inhibitors |
| JP2023513331A (ja) * | 2020-02-11 | 2023-03-30 | ヘテロ ラボズ リミテッド | Ｈｉｖ阻害剤としての新規トリテルペン誘導体 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009100532A1 (en) * | 2008-02-14 | 2009-08-20 | Virochem Pharma Inc. | NOVEL 17ß LUPANE DERIVATIVES |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5413999A (en) | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| US5869535A (en) | 1995-03-21 | 1999-02-09 | The Board Of Trustees Of The University Of Illinois | Method and composition for selectively inhibiting melanoma |
| US5962527A (en) | 1995-03-21 | 1999-10-05 | The Board Of Trustees Of The University Of Illinois | Method and composition for treating cancers |
| US5679828A (en) | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
| US20040110785A1 (en) | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US7365221B2 (en) | 2002-09-26 | 2008-04-29 | Panacos Pharmaceuticals, Inc. | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| WO2004089357A2 (en) | 2003-04-02 | 2004-10-21 | Regents Of The University Of Minnesota | Anti-fungal formulation of triterpene and essential oil |
| US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| AU2005224260A1 (en) | 2004-03-17 | 2005-09-29 | Panacos Pharmaceuticals, Inc. | Pharmaceuticals salts of 3-O-(3',3'-dimethylsuccinyl) betulinic acid |
| TW200628161A (en) | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
| WO2008127364A2 (en) | 2006-10-13 | 2008-10-23 | Myriad Genetics, Inc. | Antiviral compounds and use thereof |
| US20110144069A1 (en) | 2006-10-16 | 2011-06-16 | Myriad Genetics, Incorporated | Compounds for treating viral infections |
| US9067966B2 (en) | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
| ES2548905T3 (es) | 2010-06-04 | 2015-10-21 | Bristol-Myers Squibb Company | Amidas C-28 de derivados del ácido betulínico C-3 modificados como inhibidores de la maduración del VIH |
| EP2576585B8 (en) | 2010-06-04 | 2016-12-21 | VIIV Healthcare UK (No.5) Limited | Modified c-3 betulinic acid derivatives as hiv maturation inhibitors |
| SI2670764T1 (sl) | 2011-01-31 | 2016-03-31 | Bristol-Myers Squibb Company | C-28 amini derivatov c-3 modificirane betulinske kisline inhibitorjev zorenja hiv |
| CA2826113C (en) | 2011-01-31 | 2018-09-04 | Bristol-Myers Squibb Company | C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity |
-
2012
- 2012-09-20 MX MX2014002936A patent/MX2014002936A/es unknown
- 2012-09-20 AU AU2012312485A patent/AU2012312485B2/en not_active Ceased
- 2012-09-20 KR KR1020147010087A patent/KR20140069167A/ko not_active Ceased
- 2012-09-20 CA CA2849475A patent/CA2849475A1/en not_active Abandoned
- 2012-09-20 WO PCT/US2012/056186 patent/WO2013043778A1/en not_active Ceased
- 2012-09-20 ES ES12766825.9T patent/ES2611727T3/es active Active
- 2012-09-20 US US13/623,165 patent/US8754069B2/en not_active Expired - Fee Related
- 2012-09-20 TW TW101134558A patent/TW201317255A/zh unknown
- 2012-09-20 EA EA201490643A patent/EA023463B1/ru not_active IP Right Cessation
- 2012-09-20 CN CN201280046037.7A patent/CN103814042B/zh not_active Expired - Fee Related
- 2012-09-20 EP EP12766825.9A patent/EP2758419B8/en not_active Not-in-force
- 2012-09-20 SG SG11201400331WA patent/SG11201400331WA/en unknown
- 2012-09-20 JP JP2014531936A patent/JP6100786B2/ja not_active Expired - Fee Related
- 2012-09-20 BR BR112014006559A patent/BR112014006559A2/pt not_active IP Right Cessation
-
2014
- 2014-03-09 IL IL231421A patent/IL231421A/en not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009100532A1 (en) * | 2008-02-14 | 2009-08-20 | Virochem Pharma Inc. | NOVEL 17ß LUPANE DERIVATIVES |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2611727T3 (es) | 2017-05-10 |
| BR112014006559A2 (pt) | 2017-03-28 |
| JP6100786B2 (ja) | 2017-03-22 |
| TW201317255A (zh) | 2013-05-01 |
| KR20140069167A (ko) | 2014-06-09 |
| EA023463B1 (ru) | 2016-06-30 |
| IL231421A0 (en) | 2014-04-30 |
| SG11201400331WA (en) | 2014-08-28 |
| MX2014002936A (es) | 2014-04-25 |
| AU2012312485A1 (en) | 2014-05-08 |
| US8754069B2 (en) | 2014-06-17 |
| US20130072465A1 (en) | 2013-03-21 |
| IL231421A (en) | 2015-11-30 |
| WO2013043778A1 (en) | 2013-03-28 |
| AU2012312485B2 (en) | 2016-09-01 |
| EP2758419B1 (en) | 2016-10-19 |
| JP2014526554A (ja) | 2014-10-06 |
| EA201490643A1 (ru) | 2014-06-30 |
| CA2849475A1 (en) | 2013-03-28 |
| CN103814042A (zh) | 2014-05-21 |
| EP2758419A1 (en) | 2014-07-30 |
| EP2758419B8 (en) | 2017-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103814042B (zh) | 具有抗病毒活性的桦木酸衍生物 | |
| CN102985438B (zh) | 作为hiv成熟抑制剂的经修饰c-3桦木酸衍生物的c-28酰胺 | |
| JP5752789B2 (ja) | Ｈｉｖ成熟阻害剤としての修飾ｃ−３ベツリン酸誘導体 | |
| JP6000283B2 (ja) | Ｈｉｖ成熟阻害剤としてのｃ−３修飾ベツリン酸誘導体のｃ−２８アミン | |
| JP6155285B2 (ja) | Ｈｉｖ成熟阻害活性のあるｃ−３シクロアルケニルトリテルペノイド | |
| JP6186012B2 (ja) | Ｃ−３アルキルおよびアルケニル修飾ベツリン酸誘導体 | |
| CN104540844B (zh) | 具有hiv成熟抑制活性的三萜系化合物的c-17双环胺 | |
| KR20150115881A (ko) | Hiv 성숙 억제 활성을 갖는 c-19 변형된 트리테르페노이드 | |
| KR102411082B1 (ko) | 할로알킬 치환기를 지니는 비방향족 고리에 의해 위치 3에서 치환된，ｈｉｖ 성숙화 억제 활성을 갖는 트리테르페노이드 | |
| CN107250153A (zh) | 氧代羽扇豆烯衍生物 | |
| CN107250152A (zh) | C17‑芳基取代的桦木酸类似物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150819 Termination date: 20180920 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |